Found 21 articles for: "Mohs micrographic surgery"
Hidradenitis Suppurativa Increases Risk of Postoperative Complications After Mohs Surgery: A Retrospective Cohort Study
November 2026 | Volume 25 | Issue 11 | Editorials | e98 | Copyright © November 2026
Secondary Intention Healing Over Periosteum: Challenging the Reconstruction Algorithm for Supraperiosteal Defects
September 2026 | Volume 25 | Issue 9 | Features | 877 | Copyright © September 2026
Postoperative Complication Risks in Melanoma in situ Treated With Mohs Surgery or Wide Local Excision
September 2026 | Volume 25 | Issue 9 | Editorials | e87 | Copyright © September 2026
Increased Postoperative Risks After Mohs Surgery in Patients With Hypothyroidism: A Cohort Study
June 2026 | Volume 25 | Issue 6 | Editorials | e58 | Copyright © June 2026
Perioperative Use of Angiotensin Inhibitors and Their Complications in Mohs Surgery: A Retrospective Cohort Study
June 2026 | Volume 25 | Issue 6 | Features | e51 | Copyright © June 2026
Minimum Margins After Positive Mohs Surgery Stages Correlate With Histologic Facing Loss
May 2026 | Volume 25 | Issue 5 | Features | 477 | Copyright © May 2026
Chronic Kidney Disease and Postoperative Complications Following Mohs Surgery: A Retrospective Cohort Study
May 2026 | Volume 25 | Issue 5 | Editorials | 486 | Copyright © May 2026
Mohs Micrographic Surgery in Female Genital Cancers: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1080 | Copyright © November 2025
Background: Mohs micrographic surgery (MMS) has shown promising efficacy in female genital cancers, including Extramammary Paget’s disease (EMPD), dermatofibrosarcoma protu...
Read MoreMedical and Surgical Management of Multifocal Superficial Basal Cell Carcinoma
May 2025 | Volume 24 | Issue 5 | Original Article | 483 | Copyright © May 2025
Background: Multifocal superficial basal cell carcinoma (sBCC) is a subtype of BCC characterized by subclinical extension of noncontiguous tumor islands and high recurrence rates...
Read MoreEndocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 498 | Copyright © May 2025
Background: Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is a low-grade, cutaneous adnexal neoplasm. It is believed to have a potential for local recurrence as well a...
Read MoreEvaluating Postoperative Outcomes of Mohs Surgery in the Elderly: A Retrospective Review of Large Repairs
May 2025 | Volume 24 | Issue 5 | Features | 537 | Copyright © May 2025
Background: As the geriatric population, defined by the National Institute on Aging as 65 years and older, continues to grow exponentially, understanding how age impacts the trea...
Read MoreSurgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 444 | Copyright © May 2025
Background: Cylindromas are benign adnexal tumors often associated with conditions such as Brooke-Spiegler Syndrome and familial cylindromatosis. Cylindromas can undergo malignan...
Read MoreNeoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report
March 2025 | Volume 24 | Issue 3 | Case Reports | 329 | Copyright © March 2025
Neoadjuvant Hedgehog Pathway Inhibitor (HPI) therapy, utilizing sonidegib and vismodegib, has shown great potential in managing locally advanced basal cell carcinoma (laBCC). While effective, the...
Read MoreComparing Histological Preparation and Tumor Debulking Techniques in Mohs Micrographic Surgery: A Cross-Sectional Survey
May 2023 | Volume 22 | Issue 5 | Features | 514 | Copyright © May 2023
Mohs Micrographic Surgery in Skin of Color
May 2022 | Volume 21 | Issue 5 | Features | 536 | Copyright © May 2022
The United States population is becoming increasingly diverse. Data show increased utilization of Mohs micrographic surgery (MMS) in people of color. Though the incidence of skin cancer in skin of col...
Read MoreOpioid Prescriptions and Pain-Related Patient-Initiated Communication After Mohs Micrographic Surgery: A Retrospective Cohort Study
May 2022 | Volume 21 | Issue 5 | Editorials | 551 | Copyright © May 2022
Background: There is a wide variety in utilization of opioids during Mohs Micrographic Surgery (MMS) despite evidence that a multimodality approach may be more beneficial.
Incomplete Staining Artifact: A Confounding Frozen Section Pathology Artifact Encountered During Mohs Micrographic Surgery
May 2022 | Volume 21 | Issue 5 | Features | 544 | Copyright © May 2022
The intent of this brief communication is to describe a unique incomplete staining frozen section pathology artifact encountered during Mohs Micrographic Surgery. At the authors’ institution, an...
Read MoreImpact of the COVID Pandemic on Mohs Micrographic Surgery: A Nationwide Survey
May 2022 | Volume 21 | Issue 5 | Editorials | 545 | Copyright © May 2022
Background: At the onset of the COVID-19 pandemic, many Mohs micrographic surgeries (MMS) were delayed over concerns for propagating further infectious spread and scarcity of medic...
Read MoreConsistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery
May 2022 | Volume 21 | Issue 5 | Original Article | 506 | Copyright © May 2022
Mohs micrographic surgery (MMS) has become the standard of treatment for skin malignancies of the head and neck. However, there is a paucity of literature describing facial distributions of MMS. Anato...
Read MoreMost Patient-Oriented Video Resources Do Not Comprehensively Explain Mohs Micrographic Surgery
February 2022 | Volume 21 | Issue 2 | Editorials | 204 | Copyright © February 2022
Mohs micrographic surgery (MMS) is increasingly utilized for treatment of skin cancer, however the technique used is markedly different than other surgical modalities.1,2 Explaining MMS to ...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
